Search research articles
Contact Us
Filters
Showing results (71-80 of 101) with videos related to
Page
of 11
Sort By:
British Journal of Pharmacology
|
November 7, 1998
Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents
H A Wieland, W Engel, W Eberlein, et al.
Burns : Journal of the International Society for Burn Injuries
|
May 1, 2007
Hot air sauna burns
M Ghods, C Corterier, K Zindel, et al.
Zentralblatt Fur Gynakologie
|
January 1, 1985
[Behavior of the hypothalamo-hypophyseal unit to stimulation with arginine, GnRH and TRH in patients with chronic uremia]
K Rudolf, S Kunkel, H Rudolf, et al.
Maturitas
|
December 4, 2001
Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy: a randomized comparative dose-ranging study
M Bruhat, K Rudolf, R Vaheri, et al.
European Journal of Pharmacology
|
September 16, 2000
Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens: evidence for a [Cys(Et)(2, 7)]hCGRP-preferring receptor
D Wu, W Eberlein, K Rudolf, et al.
Zentralblatt Fur Gynakologie
|
January 1, 1989
[Evaluation of the subrenal capsule assay (SRCA) in breast cancer using immunocompetent (NIC) mice]
B Gerber, D Richter, E Rohde, et al.
Archiv Fur Geschwulstforschung
|
January 1, 1989
[Applicability of the subrenal capsule assay (SRCA) in primary breast carcinoma]
B Gerber, D Richter, E Rohde, et al.
Plos One
|
August 21, 2012
Visual adaptation to thin and fat bodies transfers across identity
Dennis Hummel, Anne K Rudolf, Karl-Heinz Untch, et al.
British Journal of Pharmacology
|
March 11, 2000
Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist
H Doods, G Hallermayer, D Wu, et al.
Experimental and Clinical Endocrinology
|
December 1, 1984
The effect of a single midcycle administration of 0.5 or 2.0 mg dienogest (17 alpha-cyanomethyl-17 beta-hydroxy-estra-4,9-dien-3-one) on pituitary and ovarian function--investigation for the use as a postcoital contraceptive
G Köhler, G Göretzlehner, K Rudolf, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 101) with videos related to
Sort By:
Page
of 11
British Journal of Pharmacology
|
November 7, 1998
Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents
H A Wieland, W Engel, W Eberlein, et al.
Burns : Journal of the International Society for Burn Injuries
|
May 1, 2007
Hot air sauna burns
M Ghods, C Corterier, K Zindel, et al.
Zentralblatt Fur Gynakologie
|
January 1, 1985
[Behavior of the hypothalamo-hypophyseal unit to stimulation with arginine, GnRH and TRH in patients with chronic uremia]
K Rudolf, S Kunkel, H Rudolf, et al.
Maturitas
|
December 4, 2001
Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy: a randomized comparative dose-ranging study
M Bruhat, K Rudolf, R Vaheri, et al.
European Journal of Pharmacology
|
September 16, 2000
Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens: evidence for a [Cys(Et)(2, 7)]hCGRP-preferring receptor
D Wu, W Eberlein, K Rudolf, et al.
Zentralblatt Fur Gynakologie
|
January 1, 1989
[Evaluation of the subrenal capsule assay (SRCA) in breast cancer using immunocompetent (NIC) mice]
B Gerber, D Richter, E Rohde, et al.
Archiv Fur Geschwulstforschung
|
January 1, 1989
[Applicability of the subrenal capsule assay (SRCA) in primary breast carcinoma]
B Gerber, D Richter, E Rohde, et al.
Plos One
|
August 21, 2012
Visual adaptation to thin and fat bodies transfers across identity
Dennis Hummel, Anne K Rudolf, Karl-Heinz Untch, et al.
British Journal of Pharmacology
|
March 11, 2000
Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist
H Doods, G Hallermayer, D Wu, et al.
Experimental and Clinical Endocrinology
|
December 1, 1984
The effect of a single midcycle administration of 0.5 or 2.0 mg dienogest (17 alpha-cyanomethyl-17 beta-hydroxy-estra-4,9-dien-3-one) on pituitary and ovarian function--investigation for the use as a postcoital contraceptive
G Köhler, G Göretzlehner, K Rudolf, et al.
Page
of 11